Technical Analysis for MDWD - MediWound Ltd.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Gapped Up | Strength | 4.13% | |
| Up 3 Days in a Row | Strength | 4.13% | |
| Upper Bollinger Band Touch | Strength | 4.13% | |
| 20 DMA Support | Bullish | 16.69% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 16.69% | |
| Calm After Storm | Range Contraction | 16.69% | |
| Down 3 Days in a Row | Weakness | 16.69% | |
| Down 4 Days in a Row | Weakness | 16.69% | |
| 20 DMA Support | Bullish | 16.61% | |
| Down 3 Days in a Row | Weakness | 16.61% |
| Alert | Time |
|---|---|
| Rose Above Upper Bollinger Band | 11 minutes ago |
| Rose Above Previous Day's High | about 2 hours ago |
| Up 3% | about 2 hours ago |
| Up 2% | about 2 hours ago |
| 60 Minute Opening Range Breakout | about 3 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/28/2024
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the treatment of severe burns, chronic and other hard-to-heal wounds, and connective tissue disorders. Its lead product candidate is EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Wound Acute Pain Burns Connective Tissue Medical Emergencies Necrosis Yavne
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Wound Acute Pain Burns Connective Tissue Medical Emergencies Necrosis Yavne
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 18.75 |
| 52 Week Low | 7.1 |
| Average Volume | 82,335 |
| 200-Day Moving Average | 11.10 |
| 50-Day Moving Average | 15.32 |
| 20-Day Moving Average | 15.89 |
| 10-Day Moving Average | 16.79 |
| Average True Range | 1.14 |
| RSI (14) | 61.69 |
| ADX | 23.99 |
| +DI | 31.24 |
| -DI | 14.52 |
| Chandelier Exit (Long, 3 ATRs) | 15.33 |
| Chandelier Exit (Short, 3 ATRs) | 16.99 |
| Upper Bollinger Bands | 18.25 |
| Lower Bollinger Band | 13.53 |
| Percent B (%b) | 0.88 |
| BandWidth | 29.72 |
| MACD Line | 0.56 |
| MACD Signal Line | 0.45 |
| MACD Histogram | 0.1069 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 19.52 | ||||
| Resistance 3 (R3) | 19.51 | 18.88 | 19.21 | ||
| Resistance 2 (R2) | 18.88 | 18.41 | 18.89 | 19.11 | |
| Resistance 1 (R1) | 18.27 | 18.11 | 17.96 | 18.28 | 19.00 |
| Pivot Point | 17.64 | 17.64 | 17.48 | 17.64 | 17.64 |
| Support 1 (S1) | 17.03 | 17.17 | 16.71 | 17.04 | 16.32 |
| Support 2 (S2) | 16.40 | 16.87 | 16.40 | 16.21 | |
| Support 3 (S3) | 15.79 | 16.40 | 16.11 | ||
| Support 4 (S4) | 15.80 |
